![David A. Lowe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David A. Lowe
Directeur Général chez
NeuroAssets Sàrl
Profil
Dr. David A. Lowe is President & Chief Executive Officer at NeuroAssets Sàrl.
He is on the Board of Directors at Amarantus Bioscience Holdings, Inc.
Dr. Lowe was previously employed as Chief Scientific Officer by Memory Pharmaceuticals Corp., Chief Scientific Officer by Fidelity Biosciences Corp., VP & Therapeutic Area Head-Central Nervous System by Roche Palo Alto LLC, VP & Global Head-Central Nervous System Research by Bayer AG, and President & Chief Executive Officer by FORUM Pharmaceuticals, Inc.
He received his undergraduate degree from the University of Bristol and a doctorate degree from the University of Leeds.
Postes actifs de David A. Lowe
| Sociétés | Poste | Début |
|---|---|---|
NeuroAssets Sàrl | Directeur Général | - |
Anciens postes connus de David A. Lowe
| Sociétés | Poste | Fin |
|---|---|---|
| AMARANTUS BIOSCIENCE HOLDINGS, INC. | Directeur/Membre du Conseil | 22/10/2015 |
Impresa Management LLC
 Impresa Management LLC Investment ManagersFinance F-Prime invests in companies located in Asia, Europe, North America and South America. The firm targets companies operating in the fields of life sciences, technology, healthtech & services and crypto sectors. It provides financing for seed, early and later stage transactions. | Directeur Technique/Scientifique/R&D | 01/01/2004 |
Roche Palo Alto LLC
 Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Discovers and develops medicines | Corporate Officer/Principal | 01/01/2002 |
| BAYER AG | Corporate Officer/Principal | 01/01/2000 |
FORUM Pharmaceuticals, Inc.
 FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for central nervous system disorders | President | - |
Formation de David A. Lowe
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
58
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Bayer AG
 Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for central nervous system disorders | Health Technology |
Roche Palo Alto LLC
Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Discovers and develops medicines | Health Technology |
Memory Pharmaceuticals Corp.
 Memory Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
University of Leeds
 University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amarantus Bioscience Holdings, Inc.
 Amarantus Bioscience Holdings, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutic products for neurology, psychiatry, ophthalmology and regenerative medicine | Health Technology |
Impresa Management LLC
Impresa Management LLC Investment ManagersFinance F-Prime invests in companies located in Asia, Europe, North America and South America. The firm targets companies operating in the fields of life sciences, technology, healthtech & services and crypto sectors. It provides financing for seed, early and later stage transactions. | Finance |
NeuroAssets Sàrl |
